Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)
Condition(s): Obesity Last Updated: March 16, 2007Active, not recruiting
Hide Studies Not Seeking New Volunteers
Condition(s): Obesity Last Updated: March 16, 2007Active, not recruiting
Condition(s): Obesity Last Updated: June 4, 2007Active, not recruiting
Condition(s): Premenstrual Syndrome Last Updated: June 15, 2010Recruiting
Condition(s): Premenstrual Syndrome Last Updated: June 15, 2010Recruiting
Condition(s): Kallmann Syndrome Last Updated: February 13, 2008Enrolling by invitation
Condition(s): Bioequivalence; Ethinylestradiol; Gestodene; Harmonet Last Updated: February 18, 2011Completed
Condition(s): Breast Cancer Last Updated: March 23, 2012Completed
Condition(s): Infertility, Female; Obesity Last Updated: March 22, 2013Recruiting
Condition(s): Healthy Last Updated: October 2, 2009Completed
Condition(s): Premature Ovarian Failure (POF); Incipient Ovarian Failure; Poor Response After Ovarian Hyperstimulation; Early Menopause; Hypergonadotropic Amenorrhea Last Updated: August 5, 2011Recruiting
Condition(s): Aging Last Updated: July 27, 2012Completed
Condition(s): Abortion, Recurrent Last Updated: August 4, 2010Recruiting
Condition(s): Breast Cancer Last Updated: June 7, 2012Terminated
Condition(s): Hot Flushes, Menopause, Postmenopause Last Updated: August 14, 2008Completed
Condition(s): Menopause Last Updated: April 10, 2008Terminated
Condition(s): Menopause Last Updated: April 10, 2008Terminated
Condition(s): Breast Neoplasms Last Updated: February 25, 2008Active, not recruiting
Condition(s): Menopause Last Updated: January 29, 2009Completed
Condition(s): Drug Toxicity Last Updated: June 25, 2007Completed